跳至主要内容
临床试验/NCT05702957
NCT05702957已完成2 期

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome: Randomised Control Trial

Services Institute of Medical Sciences, Pakistan1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2016年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
220
试验地点
1
主要终点
Pregnancy rate

研究概览

简要总结

It was randomised controlled study to compare the efficacy of clomiphene and letrozole in polycystic ovarian syndrome(PCOS) women with infertility.The aim was to select more appropriate treatment for ovulation induction in PCOS women.

详细描述

The prevalence of infertility due to polycystic ovarian syndrome in Pakistan is 21.9%.It leads to an ovulation which results in infertility.The objective of this study was to compare the efficacy of letrozole vs clomiphene citrate for ovulation induction in PCOS women.Methods.It was a randomised controlled trial conducted in department of gynaecology and obstetrics ,Services Hospital Lahore from 2016-2019.

Total 230 patients were included in study, they were divided in two groups, out of which 220 patients were analysed. .Group-A patients were given clomiphene citrate 50-150mg per day for 5 days starting from 2nd day of menses and group B patients were given letrozole 2.5-7.5mg per day for 5 days. Transvaginal ultrasound monitoring done from day 10-12 of menstrual cycle to measure follicle number and size.When follicle achieved a diameter of 18-20mm, then Inj HCG(human chorionic gonadotropin)10,000 IU intramuscular was given. Ovulation was confirmed by day 21 S.progesterone. When patient conceived, they were followed up till delivery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Two treatment groups were made by random computer generated number i.e. Group A and Group B. Two Concealed boxes labelling A and B containing study drugs were made by pharmacist.Then participants were given drug from concealed boxes according to computer generated number.

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women age between 18-40 years.
  • Normal husband semen analysis.

排除标准

  • All infertile couples who had other causes of infertility than PCOS.
  • Those who had recently taken these medications.
  • Any contraindication to use of drugs e.g renal or hepatic dysfunction, hypersensitivity to this drug.
  • BMI>35 because obese women respond poorly to ovulation induction.

研究组 & 干预措施

letrozole

Experimental

Patients were given letrozole 2.5 mg-7.5mg per day for 5 days started from 2nd day of menses.

干预措施: letrozole 2.5mg-7.5mg (Drug)

Clomiphene citrate

Active Comparator

Patients were given clomiphene citrate 50-150mg per day for 5 days started from 2nd day of the menses.

干预措施: Clomiphene Citrate 50mg-150mg (Drug)

结局指标

主要结局

Pregnancy rate

时间窗: 5th week of cycle when periods missed

Total number of patients conceived after treatment

次要结局

  • ovulation rate(10-22 day of cycle)
  • Live birth rate(9 months)
  • Monofollicular development(10-12 day of menstrual cycle)
  • Multifollicular development(10-12 day of menstrual cycle)
  • Miscarraige(Less than 24weeks)
  • Adverse effects(first 10days of cycle)

研究者

发起方
Services Institute of Medical Sciences, Pakistan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Tayyiba Wasim

Professor Obstetrics & Gynaecology

Services Institute of Medical Sciences, Pakistan

研究点 (1)

Loading locations...

相似试验